“…The culture method continues to be the gold standard for the clinical detection of bacteria in hospitals. However, this method has significant limitations including a slow process time, low detection rates, which are a result of generational time delay, and the inability to cultivate certain bacteria. , Time-of-flight mass spectrometry provides faster bacterial identification but necessitates pure cultured bacteria and expensive equipment, hindering point-of-care testing (POCT). , Furthermore, immunological methods pose challenges due to low detection sensitivity and difficulties in procuring monoclonal antibodies. , Nucleic acid-based molecular biology methods such as gene sequencing demand bulky instruments and trained operators, restricting their application to centralized laboratories. , Despite the ongoing evolution of molecular hybridization, , DNA chips, , and nucleic acid biosensors, , technologies are advancing toward expedited response, reduced costs, and simplified miniaturization, the absence of a universal target compels patients with bacterial infections to undergo a complex pathogen identification procedure, thus delaying treatment.…”